Components:
Medically reviewed by Kovalenko Svetlana Olegovna, PharmD. Last updated on 26.06.2023
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Use Ditak as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- Take Ditak by mouth with or without food.
- Ditak may increase the amount of urine or cause you to urinate more often when you first start taking it. To keep this from disturbing your sleep, try to take your dose before 6 pm.
- If you miss a dose of Ditak, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.
Ask your health care provider any questions you may have about how to use Ditak.
There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.Ditak is used to remove excess salts from the body, while retaining potassium. It is used to treat swelling due to fluid retention (oedema) in heart diseases (cardiac failure), liver diseases (cirrhosis of the liver) or kidney diseases (nephrotic syndrome), and in edema associated with corticosteroid treatment. They are used alone or in combination with other diuretic which cause potassium depletion.
See also:
What other drugs will affect Ditak?
Caution should be used when lithium and diuretics are used concomitantly because diuretic-induced sodium loss may reduce the renal clearance of lithium and increase serum lithium levels with risk of lithium toxicity. Patients receiving such combined therapy should have serum lithium levels monitored closely and the lithium dosage adjusted if necessary.
A possible interaction resulting in acute renal failure has been reported in a few subjects when indomethacin, a nonsteroidal anti-inflammatory agent, was given with Ditak. Caution is advised in administering nonsteroidal anti-inflammatory agents with Ditak.
The effects of the following drugs may be potentiated when given together with Ditak: antihypertensive medication, other diuretics, preanesthetic and anesthetic agents, skeletal muscle relaxants (nondepolarizing).
Potassium-sparing agents should be used with caution in conjunction with angiotensin-converting enzyme (ACE) inhibitors due to an increased risk of hyperkalemia.
The following agents, given together with Ditak, may promote serum potassium accumulation and possibly result in hyperkalemia because of the potassium-sparing nature of Ditak, especially in patients with renal insufficiency: blood from blood bank (may contain up to 30 mEq of potassium per liter of plasma or up to 65 mEq per liter of whole blood when stored for more than 10 days); low-salt milk (may contain up to 60 mEq of potassium per liter); potassium-containing medications (such as parenteral penicillin G potassium); salt substitutes (most contain substantial amounts of potassium).
Ditak (Ditak) may raise blood glucose levels; for adult-onset diabetes, dosage adjustments of hypoglycemic agents may be necessary during and/or after therapy; concurrent use with chlorpropamide may increase the risk of severe hyponatremia.
Drug/Laboratory Test Interactions
Ditak and quinidine have similar fluorescence spectra; thus, Ditak will interfere with the fluorescent measurement of quinidine.